Evidence map›Paper›PMID 21328710›Full record

ArticleJournal of bioinformatics and computational biology2011

A novel approach to DNA copy number data segmentation.

Siling Wang, Yuhang Wang, Yang Xie, Guanghua Xiao

Abstract readComparative StudyEvaluation Study
In one paragraph

Article in Journal of bioinformatics and computational biology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Siling WangDepartment of Computer Science and Engineering, Southern Methodist University, Dallas, Texas 75205, USA. silingw@smu.edu
Yuhang Wang
Yang Xie
Guanghua Xiao

Funding

Predicting Adjuvant Chemotherapy Response in Lung CancerR01CA152301 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI XIE, YANG · 2010 to 2014
$1.5M
Secondary Data Analyses for Substance Abuse ResearchR33DA027592 · NIDA · UT SOUTHWESTERN MEDICAL CENTER · PI XIAO, GUANGHUA · 2011 to 2012
$622k
Secondary Data Analyses for Substance Abuse ResearchR21DA027592 · NIDA · UT SOUTHWESTERN MEDICAL CENTER · PI XIAO, GUANGHUA · 2009 to 2010
$506k
NCI NIH HHS 1R01CA152301-01NCI NIH HHS R01 CA152301NIDA NIH HHS 1R21DA027592NIDA NIH HHS R21 DA027592NIDA NIH HHS R33 DA027592
6 · The paper itself

Abstract

DNA copy number (DCN) is the number of copies of DNA at a region of a genome. The alterations of DCN are highly associated with the development of different tumors. Recently, microarray technologies are being employed to detect DCN changes at many loci at the same time in tumor samples. The resulting DCN data are often very noisy, and the tumor sample is often contaminated by normal cells. The goal of computational analysis of array-based DCN data is to infer the underlying DCNs from raw DCN data. Previous methods for this task do not model the tumor/normal cell mixture ratio explicitly and they cannot output segments with DCN annotations. We developed a novel model-based method using the minimum description length (MDL) principle for DCN data segmentation. Our new method can output underlying DCN for each chromosomal segment, and at the same time, infer the underlying tumor proportion in the test samples. Empirical results show that our method achieves better accuracies on average as compared to three previous methods, namely Circular Binary Segmentation, Hidden Markov Model and Ultrasome.

Indexed as

DNA Copy Number VariationsAlgorithmsComputational BiologyComputer SimulationDatabases, Nucleic AcidData Interpretation, StatisticalDNA, NeoplasmHumansMarkov ChainsModels, StatisticalNeoplasmsOligonucleotide Array Sequence AnalysisSoftwareDNA, Neoplasm

Identifiers

PMID21328710
PMCPMC3084615

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.